Apoptosis plays a critical role in the development and homeostasis of tissues, especially those with high cell turnover such as the lymphoid system. We have examined the effects of thyroid hormones, TSH and TRH, on apoptosis of human T lymphocytes. We found that T lymphocytes cultured with T 3 and T 4 , but not TSH nor TRH, in vitro showed enhanced apoptosis, evidenced by DNA ladder formation and characteristic morphological changes. In addition, prolonged cultivation with thyroid hormones of the lymphocytes further enhanced the extent of apoptosis.
A POPTOSIS plays a critical role in the development and homeostasis of multicellular organisms (1) (2) (3) (4) (5) . An increased rate of apoptosis is involved in the pathogenesis of several degenerative diseases (6 -9) . Conversely, inhibition of apoptosis has been implicated in autoimmune diseases and carcinogenesis (8 -10) . It is now clear that members of the cysteine proteases encoded by the mammalian ICE gene family play a key role in driving apoptosis (11) (12) (13) . To date, 10 homologs of human ICE protease, which are now named caspase-1 to -10, have been reported (14) . On the other hand, the protooncogene bcl-2 has the ability to inhibit apoptosis of various cell types induced by a variety of stimuli (15, 16) .
Glucocorticoid (GC), thyroid hormone, and retinoic acid contribute to vertebrate development and homeostasis by serving as biological signals to control cellular functions, including cell growth and cell death (17) (18) (19) . GC receptor, thyroid hormone receptor, and retinoic acid receptor, members of the GC-thyroid hormone-retinoic acid receptor family, share many characteristics for exerting their actions on gene transcription. Upon binding to their respective hormones, intracellular receptors for these hormones act as dimeric transcription factors to activate or repress expression of nuclear target genes by binding to specific DNA sequences termed hormone response elements (20, 21) .
It is well known that thyroid hormones contribute to the development and maintenance of homeostasis in multicellular organisms to control cell growth and differentiation (22, 23) . Thyroid hormones, for example, influence mammalian central nervous system morphogenesis (24) . In addition, cell death during amphibian metamorphosis (involving apoptosis) is under the control of thyroid hormones (25) (26) (27) . It has been reported that thyroid hormone induces apoptotic cell death of differentiating erythrocytic progenitor cells (24) . On the contrary, thyroid hormone inhibits apoptosis of early differentiating cerebellar granule neurons by inducing enhanced expression of antiapoptotic Bcl-2 protein (28) .
GC and retinoic acid have been shown to induce apoptotic cell death of many cell types, including leukocytes and lymphocytes (29 -32) . Regardless of the structural and functional similarities of the GC-thyroid hormone-retinoic acid receptor family, it is not clear whether the thyroid hormone/thyroid hormone receptor complex mediates apoptosis of peripheral blood lymphocytes (PBL) in humans.
In the present study, we have investigated the effects of thyroid hormones on human lymphocyte apoptosis. We show here that thyroid hormones induce apoptotic cell death of a human T cell line and circulating lymphocytes. nmol/L) and low titer of TSH (all Ͻ0.1 mU/L; normal, 0.4 -4.7 mU/L) were studied. Their mean age Ϯ sd was 31.0 Ϯ 5.3 yr. Lymphocytes from 10 normal volunteer donors (8 males and 2 females; mean age Ϯ sd, 34.7 Ϯ 9.5 yr) were also studied. PBL were isolated by centrifugation of the heparinized blood through Ficoll/Hypaque (Nakarai Tesque, Kyoto, Japan). T lymphocytes were purified using the neuraminidase-treated sheep red blood cell rosette technique (33) . CD4 ϩ T lymphocytes and CD8 ϩ T lymphocytes were separated using the magnetic bead method as previously reported (34) . Lymphocytes were cultured in RPMI 1640 (Nikken Bio Medical Laboratory, Kyoto, Japan) supplemented with 10% FCS, penicillin (100 U/mL), and streptomycin (100 g/mL; the latter three from Life Technologies, Gaithersburg, MD), followed by analysis of apoptotic cell death. Original Jurkat cells were weaned from RPMI 1640 containing 10% FCS and were cultured in Nutridoma serum-free medium (Boehringer Mannheim, Mannheim, Germany) to avoid possible influences of various hormones present in FCS. The Jurkat cells, termed Jurkat-NU cells, were cultured in medium with T 3 , T 4 , TSH, and TRH (all from Sigma Chemical Co., St. Louis, MO) for the indicated periods. One half-volume of the medium containing the hormones was exchanged every other day.
Western blotting analysis
The cell pellets were lysed in PBS containing 0.1% Nonidet P-40 (Sigma Chemical Co.) and protease inhibitors (35) . The samples were spun at 15,000 rpm for 20 min at 4 C. Supernatants were harvested, and equivalent amounts of proteins from the Jurkat-NU cells or the PBL were resolved by 4 -20% SDS-PAGE under reducing conditions. The proteins were transferred onto polyvinylidene difluoride membranes (Millipore Corp., Bedford, MA) and were blocked with 2.5% BSA overnight. The blots were probed with the appropriate first antibody described below, followed by biotin-labeled goat antimouse IgG antibody and peroxidase-conjugated streptavidin. Detection was carried out using the enhanced chemiluminescence kit (Amersham International, Aylesbury, UK). The intensity of the detected bands was analyzed with gel-plotting macros in NIH Image 1.55 software. Anti-Bcl-2 (Dako Corp., Glostrup, Denmark) and anticaspase-3 (CPP32) (Transduction Laboratories, Inc., Lexington, KT) were used in this study.
Apoptosis assays
The extent of apoptotic cell death was estimated by the terminal deoxynucleotidyl transferase-mediated deoxy-UTP nick end labeling (TUNEL) method (36) . DNA staining with propidium iodide (PI) (37) and DNA ladder formation (38) and microscopic analysis are described below.
To detect DNA strand breaks, which are intimately associated with an apoptotic response, an in situ cell death detection kit (Boehringer Mannheim, Mannheim, Germany), where nicked DNA of fixed cells were labeled by the incorporation of fluorescein-conjugated deoxy-UTP at strand breaks by terminal deoxynucleotidyl transferase, was used (36) . The labeled cells were analyzed using a flow cytometer (36, 39) .
The reduced DNA content of apoptotic nuclei appeared as a broad hypodiploid DNA peak in the red fluorescence channels after PI staining. Analysis of hypodiploid DNA was performed as previously described (37) . Briefly, the cell pellet was resuspended in hypotonic fluorochrome solution [50 mg/mL PI (Wako, Osaka, Japan) in 0.1% sodium citrate (Wako) plus 0.1% Triton X-100 (Sigma Chemical Co.)] at 4 C in the dark overnight. The PI fluorescence of isolated nuclei was measured, and the percentage of apoptotic nuclei (subdiploid DNA peak in the DNA fluorescence histogram) was calculated using the Consort 30 program (39) .
Gel electrophoresis was used to determine nucleosomal DNA fragmentation (39) . Jurkat-NU cells were cultured for 2 weeks with or without thyroid hormones. Thereafter, total cellular DNA was recovered using a standard procedure (38) . To observe morphological changes, Jurkat-NU cells treated with or without thyroid hormones were cultured for 2 weeks. Cytospin preparations were made and then stained with Diff-Quick Solution (International Reagents Corp., Kobe, Japan).
Flow cytometric analysis of mitochondrial ⌬⌿ and ROS generation
Mitochondrial ⌬⌿ and superoxide anion (O 2 Ϫ ) generation were measured as previously described (40 -44) . Briefly, cells (5 ϫ 10 5 ) were incubated with 3,3Ј-dihexyloxacarbocyanine iodide [DiOC6(3), 40 nmol/L in PBS; Molecular Probes, Inc., Eugene, OR] and dihydroethidine (HE; 2 mol/L; Molecular Probes, Inc.) for 15 min at 37 C. In the control experiments, cells were stimulated with a radical-generating agent, menadione (1 mmol/L, 37 C, 30 min; Sigma Chemical Co.), or an uncoupling agent, carbonyl cyanide m-chlorophenylhydrazone (50 mol/L, 37 C, 30 min; Sigma Chemical Co.). Thereafter, the cells were analyzed on a flow cytometer to measure mitochondrial ⌬⌿ and ROS (O 2 Ϫ ) generation.
Statistical analysis
Analysis of the percent apoptosis of thyroid hormone-treated Jurkat-NU cells was performed using Dunn's test. Analysis of the percent apoptosis of thyroid hormone-treated PBL, T lymphocytes, CD4
ϩ T lymphocytes, and CD8 ϩ T lymphocytes was performed using Student's t test. The difference in the extent of lymphocyte apoptosis between patients with hyperthyroidism and normal individuals was compared using Mann-Whitney's U test. In the statistical analysis, P Ͻ 0.05 was considered significant.
Results

Effects of thyroid hormones on lymphocyte apoptosis
We first studied the effects of T 3 , T 4 , TSH, and TRH on apoptosis of a T cell line, Jurkat cells. To avoid the possible influences of various hormones contained in FCS, we used a serum-free culture medium that is totally free from contaminating hormones. We designated these Jurkat cells as Jurkat-NU cells. Jurkat-NU cells were cultured in the serum-free medium with T 3 and T 4 . The extent of apoptosis was estimated by the TUNEL method, which detects DNA strand breaks of apoptotic cells. We found that Jurkat-NU cells cultured for 2 weeks with T 3 and T 4 showed enhanced apoptosis compared to the cells without thyroid hormones (T 3 , P Ͻ 0.01 vs. medium; T 4 , P Ͻ 0.01 vs. medium; Fig. 1 ). Thus, it is suggested that T 4 as well as T 3 are potent inducers of lymphocyte apoptosis. The apoptosis inducing potential of T 4 and T 3 was confirmed using DNA staining with PI, which is a rapid and reliable method for detecting apoptotic cells with a flow cytometer ( Fig. 2A) (37) . TSH and TRH, on the other hand, did not show any effect on lymphocyte apoptosis in this culture system (Fig. 2B) . Furthermore, morphological analysis, which showed characteristic apoptotic bodies and nuclear fragmentation (Fig. 3) and DNA ladder formation (Fig. 4) of Jurkat-NU cells, confirmed the apoptotic nature of thyroid hormone-induced lymphocyte death. These results indicate that thyroid hormones, including T 3 and T 4 , induce apoptotic cell death of a T lymphocyte cell line.
To study the effects of thyroid hormones on apoptosis of circulating lymphocytes, PBL, T lymphocytes, and T cell subsets from healthy volunteers were cultured with or without thyroid hormones for 5 days in 10% FCS-RPMI 1640 medium. Cultivation of normal PBL for more than 6 days in this medium induced spontaneous lymphocyte apoptosis. Thus, we used 5 days of culture where spontaneous apoptosis was negligible. As shown in Fig. 5 , an increase in the percent apoptosis was seen when PBL and T lymphocytes were cultured with T 3 hormone. In addition, T 3 hormone treatment enhanced apoptosis of both CD4 ϩ T lymphocytes and CD8 ϩ T lymphocytes. The percent increase in apoptotic cells by T 3 hormone was not remarkable in this short term culture (for 5 days). The finding was highly reproducible and in the case of T 3 hormone, the difference was statistically significant (P Ͻ 0.05, by Student's t test). Treatment with T 4 hormone somehow enhanced the apoptosis of normal lymphocytes; however, the enhancement was not statistically significant. These results suggest that thyroid hormones induce apoptotic cell death of normal circulating lymphocytes as well.
Disruption of the mitochondrial ⌬⌿ and generation of O 2
Ϫ in the thyroid hormone-induced apoptotic lymphocytes
It has been shown that cells induced to undergo apoptosis accompany an early reduction in the incorporation of mitochondrial ⌬⌿-sensitive dye, DiOC6(3), indicating that a fall in the mitochondrial ⌬⌿ is associated with apoptotic cell death (45, 46) . This mitochondrial ⌬⌿ disruption can be detected in many different cell types regardless of the apoptosis-inducing stimulus. Indeed, GC-and Fas-induced apoptotic lymphocytes showed reduction of mitochondrial ⌬⌿ (29, 40 -44) . It has been reported that reduction of mitochondrial ⌬⌿ is an early irreversible step of apoptotic response (46) . Concomitantly, mitochondrial ROS generation was detected during apoptosis (40 -44, 46 -48) . We next examined the reduction of mitochondrial ⌬⌿ and the generation of O 2 Ϫ , one of ROS, in lymphocytes treated with thyroid hormones. To this end, Jurkat-NU cells and normal PBL were cultured for 2 weeks and 5 days, respectively, followed by incubation with DiOC6(3) and HE. T 3 and T 4 clearly reduced mitochondrial ⌬⌿ in Jurkat-NU cells (Fig. 6A ) and normal PBL (Fig. 6B) . We also found generation of O 2 Ϫ in Jurkat-NU cells (Fig. 7A ) and normal PBL (Fig. 7B ) treated with thyroid hormones. Taken together, these data indicate that thyroid hormones reduce the mitochondrial ⌬⌿ and induce O 2 Ϫ production, both of which lead to apoptotic cell death of lymphocytes.
Apoptosis-associated protein expression of Jurkat-NU cells cultured with thyroid hormones
We next examined the expression of apoptosis-associated proteins of Jurkat-NU cells cultured with T 3 and T 4 by the Western blotting method. We were interested in the expression of a representative antiapoptotic protein, Bcl-2, that has been reported to have antioxidant activity (49, 50) . We found that Bcl-2 expression was clearly reduced in Jurkat-NU cells treated with T 3 (Fig. 8, upper panel 
mol/L T 3 , 93%; 10
Ϫ8 mol/L T 3 , 59%; 10 Ϫ7 mol/L T 3 , 43%; and 10 Ϫ7 mol/L T 4 , 68%). The reduction of Bcl-2 protein expression was depend on the dose of thyroid hormones. On the other hand, there was no significant change in apoptosisinducing proteases such as caspase-3 (CPP32; Fig. 8 , lower panel; medium, 100%; 10 Ϫ9 mol/L T 3 , 105%; 10 Ϫ8 mol/L T 3 , 91%; 10 Ϫ7 mol/L T 3 , 93%; and 10 Ϫ7 mol/L T 4 , 95%).
Enhanced apoptosis of PBL in patients with Graves' disease
Our in vitro study clearly revealed that thyroid hormones induce apoptosis in a Jurkat-NU cell line and normal lymphocytes. Because circulating thyroid hormone levels are high in patients with hyperthyroidism, lymphocyte apoptosis should be enhanced in patients with Graves' disease, which is the most common cause of hyperthyroidism. Reports that there is a significant decrease in peripheral blood T lymphocytes in patients with Graves' disease (51-53) may relate to the accelerated apoptosis by thyroid hormones in the patients. Indeed, when we analyzed the extent of apoptosis of PBL from the patients, 5-25% of PBL from the patients spontaneously underwent apoptosis, whereas PBL from almost all normal individuals did not die via apoptosis spontaneously (Fig. 9) . Thus, thyroid hormones induce accelerated lymphocyte apoptosis in vivo and in vitro.
Discussion
In the present study, we found that thyroid hormones reduce Bcl-2 expression and induce intracellular oxidation, resulting in the induction of lymphocyte apoptosis. In addition, prolonged cultivation with thyroid hormones of the lymphocytes further enhanced the extent of apoptosis (data not shown). We also found that dehydroepiandrosterone did not enhance apoptotic cell death of Jurkat-NU cells (data not shown), confirming the specificity of the action for thyroid ϩ T lymphocytes, and CD8 ϩ T lymphocytes from normal individuals were cultured for 5 days in the presence of T 3 (10 Ϫ8 mol/L). The extent of apoptosis of T 3 -treated lymphocytes was estimated using the PI staining method. The enhancement by T 3 of lymphocyte apoptosis was weak; nevertheless, the results were highly reproducible and significant by Student's t test. We obtained similar results in five independent experiments. Data presented are the mean Ϯ SEM of triplicate samples. *, P Ͻ 0.05 vs. medium. T 4 hormone treatment somehow enhanced apoptosis of normal lymphocytes. However, the enhancement was not statistically significant. Thus, the results of such experiments were omitted.
hormones. It has been reported that thyroid hormones exert positive and negative influences on cellular apoptosis; thyroid hormone induces apoptotic cell death of differentiating erythrocytic progenitor cells (23) ; T 3 potentiates all-transretinoic acid-induced apoptosis during differentiation of the promyeloleukemic cells HL-60 (54) . In contrast, thyroid hormone inhibits apoptosis of early differentiating cerebellar granule neurons through an increase in the amounts of Bcl-2 protein (28). Retinoic acid, which is also one of the nuclear receptor gene superfamily, induces apoptosis in leukemic HL-60 cells, peripheral T cell lymphoma, and embryonal stem cells, P19EC (16, 31, 32, 55) . Retinoic acid reduces Bcl-2 expression, resulting in the induction of apoptotic cell death of leukocytes (55) . Overexpression of Bcl-2 inhibits retinoic acid-induced apoptosis in HL-60 and P19EC cells (16, 55) . It is well known that GC induce apoptosis of lymphocytes (30) . Thus, it is now clear that members of the nuclear receptor gene superfamily, including thyroid hormone receptor, modulate apoptotic cell death of leukocytes/lymphocytes. We found that thyroid hormones have an apoptosis-inducing effect on PBL. However, the effect seems to be rather weak. This may be due to the fact that the thyroid hormones have a weak apoptosis-inducing effect on PBL. Or, alternatively, fresh PBL may be apoptosis resistant. It is known that anti-Fas antibody, which has a potent apoptosis-inducing effect, induces weak apoptotic cell death of fresh PBL (56) . GC hormones, which are well known as having an apoptosisinducing effect on lymphocytes, show instead a weak effect on fresh PBL, and higher concentrations of GC hormones are required for inducing apoptosis of PBL (57) . To clarify this issue, further studies are needed to identify the critical apoptosis-inducing molecule(s) whose expression/function is modulated by the thyroid hormone.
It has been reported that the addition of ROS or the depletion of endogenous antioxidants can induce apoptotic cell death, and that apoptosis can be inhibited by endogenous or exogenous antioxidants (47, 49, 58) . Moreover, apoptosis is sometimes associated with increases in intracellular ROS levels (47, 49, 58) . It has been reported that Bcl-2 protein exerts antioxidant effects in certain in vitro systems (49, 50) . We observed that intracellular oxidation was increased in thyroid hormone-treated lymphocytes. Thus, enhanced apoptosis of thyroid hormone-treated lymphocytes may be due to the enhanced ROS production and/or the reduction of antioxidant effects by decreasing Bcl-2 protein expression.
Several models of Bcl-2 function have been proposed. Bcl-2 acts in an antioxidant pathway to decrease the generation of ROS and free radical, which induces apoptotic cell death (49, 50) . Bcl-2 prevents activation of the caspase cascade (59) . Overexpression of Bcl-2 prevents both mitochondrial ⌬⌿ disruption and apoptosis induced by DNA damage, GC, and ceramide (46) . Disruption of the mitochondrial ⌬⌿, which results from the asymmetric distribution of protons and other ions on both sides of the inner mitochondrial membrane, can be detected in many different cell types regardless of the apoptosis-inducing stimulus, such as dexamethasone, Fas cross-linking, and irradiation (46) . This mitochondrial ⌬⌿ disruption occurs before nuclear DNA fragmentation and constitutes an early irreversible step of apoptosis. Our study clearly showed that thyroid hormones induce mitochondrial ⌬⌿ disruption and reduce Bcl-2 expression, further confirming the apoptosis-inducing potential of thyroid hormones.
We found that thyroid hormone receptor is expressed constitutively on both normal PBL and Jurkat-NU cells by RT-PCR (data not shown). The results suggest that thyroid hormone receptor (and thyroid hormone complex) may be involved in the apoptosis-inducing effect of thyroid hormones, even though we cannot neglect the possibility that thyroid hormones directly exert the proapoptotic effect without participation of the receptor.
Graves' disease, the most common cause of hyperthyroidism, is caused by an agonistic anti-TSH receptor antibody, resulting in overproduction of thyroid hormones (60) . It has been shown that there is a significant decrease in peripheral blood T lymphocytes in Graves' disease (51) (52) (53) . In fact, we found that PBL from patients with Graves' disease with a high titer of circulating T 3 and T 4 showed enhanced apoptosis compared with those from normal donors. Thus, it is possible that thyroid hormones induce apoptotic cell death of lymphocytes, resulting in lymphocytopenia of circulating blood in patients with Graves' disease. We have also studied Bcl-2 protein expression in patients with Graves' disease (data not shown). We found reduction of antiapoptotic Bcl-2 protein expression in most, but not all, patients with Graves' disease. These data indicate that the mechanism of lymphocyte apoptosis in patients with Graves' disease is at least in part shared with that elucidated by our present in vitro study. Autoimmune responses, including production of anti-TSH receptor autoantibody, are associated with the pathogenesis of Graves' disease (60) . It is of interest to study whether enhanced lymphocyte apoptosis may contribute to the autoimmune responses that are associated with the pathogenesis in patients with Graves' disease.
In summary, our results indicate that thyroid hormones induce lymphocyte apoptosis in vitro and in patients with Graves' disease. 9 . Analysis of apoptotic cell death of normal PBL in patients with hyperthyroidism. PBL from 10 patients with hyperthyroidism and 10 normal volunteers were recovered and cultured for 24 h in the culture medium consisting of 10% FCS-RPMI 1640. The extent of apoptosis was estimated by DNA staining with PI. Lymphocyte apoptosis was enhanced significantly in patients with hyperthyroidism compared with that in normal controls (P Ͻ 0.05, by Mann-Whitney U test).
